Twynsta
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Twynsta, covering 2015-07-27 to 2018-10-22. Get the full timeline:
Most recent: Clinical Trial Update: A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy